dorzolamide + thimolol
Contains two active components, dorzolamide and thymalol, each of which reduces increased intraocular pressure by reducing intraocular fluid secretion. The combined effect of these substances results in a more pronounced reduction of intraocular pressure.
Drug indication: The drug is used to treat increased intraocular pressure in open-angle glaucoma and pseudo-exfoliative glaucoma with insufficient monotherapy effectiveness.
Drug effects: Reduces ocular pressure by 33-45% and maintains intraocular pressure for 24 hours.
Composition: Dorzolamide 20.0 mg, timolol 5.0 mg.
Form of production: Eye drops 20 mg/ml + 5 mg/ml.
5 ml in a bottle with a drip dispenser.